Bepotastine
| CAS No. | 190786-43-7 | Cat. No. | BCP21823 |
| Name | Bepotastine | ||
| Synonyms | TAU284; TAU-284; TAU 284; Bepreve; | ||
| Formula | C21H25ClN2O3 | M. Wt | 388.89 |
| Description | Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. Bepotastine was approved in Japan for use in the treatment of allergic rhinitis and uriticaria/puritus in July 2000 and January 2002, respectively, and is marketed by Tanabe Seiyaku Co., Ltd. under the brand name Talion. It is available in oral and opthalmic dosage forms in Japan. The opthalmic solution is FDA approved since Sept 8, 2009 and is under the brand name Bepreve. | ||
| Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | Histamine Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.